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Abstract
Mendelian randomization uses genetic variants to make causal inferences about a modifiable exposure. Subject to a genetic
variant satisfying the instrumental variable assumptions, an association between the variant and outcome implies a causal
effect of the exposure on the outcome. Complications arise with a binary exposure that is a dichotomization of a continuous
risk factor (for example, hypertension is a dichotomization of blood pressure). This can lead to violation of the exclusion
restriction assumption: the genetic variant can influence the outcome via the continuous risk factor even if the binary
exposure does not change. Provided the instrumental variable assumptions are satisfied for the underlying continuous risk
factor, causal inferences for the binary exposure are valid for the continuous risk factor. Causal estimates for the binary
exposure assume the causal effect is a stepwise function at the point of dichotomization. Even then, estimation requires
further parametric assumptions. Under monotonicity, the causal estimate represents the average causal effect in ‘com-
pliers’, individuals for whom the binary exposure would be present if they have the genetic variant and absent otherwise.
Unlike in randomized trials, genetic compliers are unlikely to be a large or representative subgroup of the population.
Under homogeneity, the causal effect of the exposure on the outcome is assumed constant in all individuals; rarely a
plausible assumption. We here provide methods for causal estimation with a binary exposure (although subject to all the
above caveats). Mendelian randomization investigations with a dichotomized binary exposure should be conceptualized in
terms of an underlying continuous variable.
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Mendelian randomization is the use of genetic variants as
instrumental variables to test for or estimate the causal
effect of a risk factor (referred to here as an exposure) on
an outcome using observational data [11, 12]. The primary
objective of Mendelian randomization is to find modifiable
exposures that are worthwhile therapeutic targets and can
be intervened on to improve health outcomes. An instru-
mental variable must be associated with the exposure of
interest (relevance), only affects the outcome through the
exposure (exclusion restriction), and does not share any
causes with the outcome (exchangeability). Recently, sev-
eral Mendelian randomization studies have employed bin-
ary measures as the exposure variable. Examples include
analyses assessing the causal effect of cannabis initiation
on schizophrenia (and of schizophrenia on cannabis initi-
ation) [14, 24], and of diabetes status on endometrial
cancer [17]. In this short manuscript, we discuss issues
relating to causal estimation in the Mendelian randomiza-
tion setting with a binary exposure. For ease of presenta-
tion, we initially assume a single genetic variant is used as
an instrumental variable; this restriction is later relaxed.
The intended primary audience of this manuscript is
Mendelian randomization practitioners, and the aim of the
manuscript is to communicate the practical consequences
of these methodological issues for Mendelian randomiza-
tion investigations. As such, we focus on methods and
approaches that are likely to be the most relevant to sce-
narios that are common in applied practice. In particular,
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we focus on methods that can be performed using sum-
marized data, which comprise genetic associations with the
exposure estimated using regression methods, that are
routinely reported by large consortia [9]. Although our
focus is on practitioners, we also provide technical asides
and references for methodologically-focused readers.
Random assignment in a trial as a paradigm
instrumental variable
Consider a double-blind, placebo-controlled randomized
trial with two time-fixed treatment arms (referred to as
treatment and control) and complete follow-up data. An
intention-to-treat effect estimate is typically reported: the
causal effect of allocation to treatment as opposed to
control. When there is substantial non-compliance, inves-
tigators may be interested in testing whether the treatment
itself has an effect on the outcome (as opposed to simply
allocation to treatment), or in estimating the causal effect
of the treatment itself. Testing for a treatment or ‘per-
protocol’ effect can be achieved through the intention-to-
treat analysis: unless random assignment somehow affects
the outcome directly (e.g., because blinding is broken or a
placebo effect is present), an association between treatment
allocation and the outcome will only arise if the treatment
has a causal effect on the outcome [13]. Estimating the
average treatment effect in the full study population further
requires additional homogeneity conditions [4, 15, 25];
sufficient conditions are linearity of the instrumental vari-
able-exposure, instrumental variable-outcome and expo-
sure–outcome relationships with no effect heterogeneity.
Without additional conditions, only bounds for the average
treatment effect are obtainable [5]. These bounds can also
be used to assess the validity of a genetic variant as an
instrumental variable [19, 21], although this approach is
rarely informative in practice, and alternative ways of
assessing instrument validity (such as understanding the
biological role of the genetic variant, and assessing its
associations with known confounders) are more likely to be
fruitful in practice [10].
As an alternative to estimating the average treatment
effect in the full population, investigators often estimate an
effect in a subgroup of the population under a weaker
assumption. Specifically, we consider the subgroup of the
population consisting of ‘compliers’—individuals who
would receive the treatment if allocated to treatment, and
would not receive treatment if allocated to not receive
treatment. The effect in this subgroup can be estimated
under the assumption that there are no defiers—individuals
who would only take treatment if randomly allocated not to
do so, and who would not take treatment if allocated to take
it [2]. This is known as the monotonicity assumption—
allocation to taking the treatment can only increase the
value of the exposure, not decrease it. This effect, which
can be estimated using standard instrumental variable
techniques, is known as the local average treatment effect
(LATE) or the complier average causal effect (CACE) in
the literature [27]. Of note, we cannot identify individual
compliers as we cannot see individuals’ treatment levels
under both levels of treatment allocation. However, it is
possible to identify the proportion of the study population
who are compliers, and to describe relative characteristics
of the compliers compared to non-compliers using mea-
sured baseline covariates [3]. In well-designed randomized
trials, compliers are likely to be common, and the
assumption that there are no defiers is often considered
reasonable.
Who are the genetic ‘compliers’?
Monotonicity in the context of Mendelian randomization
means that increasing the number of effect alleles for an
individual can only increase the exposure from absent to
present (or leave it constant), and can never decrease it.
(We here define the effect allele as the exposure-increasing
allele without loss of generality.) The analogue of ‘com-
pliers’ in Mendelian randomization are individuals who
would have the exposure present if they possess an expo-
sure-increasing allele, but would not otherwise. As genetic
variants tend to have small effects on phenotypic variables,
such compliers are likely to be uncommon.
This means that the group of genetic compliers is not
likely to be representative of the general population. Also,
the group of compliers may well differ greatly between
different study populations. As an example, folate defi-
ciency has been hypothesized as a causal risk factor for
coronary heart disease [16]. The complier population (and
therefore the instrumental variable estimate) would differ
greatly in a population where large numbers of people are
borderline folate deficient compared with a population
where relatively few people are folate deficient. (A similar
problem would occur in randomized trials conducted in
different populations.) The analogous assumption in Men-
delian randomization to the ‘no defiers’ assumption is that
increases in the genotype variable would lead to increases
(or no change) in the exposure for all individuals in the
population (or equivalently, decreases or no change in the
exposure for all individuals) [15]. With a genetic variant
that takes multiple values, the equivalent assumption is that
the exposure is a non-decreasing (or non-increasing)
function of the genetic variant. In this case (and in the case
with multiple genetic variants), the instrumental variable
estimate is a weighted average of LATEs [1].
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In the context of RCTs, even if individual compliers
cannot be identified, the subgroup of compliers may be of
interest either because it represents a large or representative
subgroup of the population, or due to patterns of non-
compliance in the trial being anticipated to be repeated
outside the trial setting. However, in Mendelian random-
ization, the subgroup of genetic ‘compliers’ is unlikely to
represent those individuals in the population who would
respond to a treatment that influences the target exposure,
particularly if the treatment has a greater effect on the risk
factor than the genetic variant. Hence, under the ‘no defi-
ers’ assumption, the interpretation of a causal estimate in a
Mendelian randomization investigation in which the
instrumental variable assumptions are satisfied is that of an
average causal effect in those individuals whose exposure
status would vary depending on whether they have a par-
ticular genetic variant or not. We additionally note that the
subgroup of genetic compliers would differ between
genetic variants. This provides yet another reason why
causal estimates based on different genetic variants may
vary even if all the genetic variants are valid instruments.
What is the true risk factor underlying
the exposure?
The above interpretation assumes that the instrumental
variable assumptions are satisfied. These assumptions
imply that the only influence of the instrumental variable
on the outcome is via the exposure—if the instrumental
variable changes, but the exposure stays the same, then the
outcome should not change. However, for most binary
exposures used in Mendelian randomization investigations,
there is an underlying continuous risk factor for which the
binary variable is a dichotomization. As a simple example,
the binary exposure hypertension is a dichotomization of
the continuous risk factor blood pressure. In more complex
examples, an underlying continuous latent variable can be
hypothesized even if it cannot be measured, such as a
continuous spectrum of sub-clinical mental health prob-
lems for the binary exposure schizophrenia.
If the binary exposure is a dichotomization of a con-
tinuous risk factor, then the instrumental variable
assumptions are likely to be violated. For the example of
hypertension, if elevated blood pressure is a causal risk
factor for a particular outcome then genetic variants that
are associated with blood pressure will be associated with
the outcome even in a population where no-one suffers
from clinically-defined hypertension. Hence, changes in
the genetic variants will lead to increases in blood pressure
and consequently to changes in the outcome even if the
exposure status for hypertension remains fixed for all
individuals in the population. An instrumental variable for
a continuous exposure can only be an instrumental variable
for the dichotomization of the exposure if the exposure–
outcome causal relationship is a strict stepwise threshold at
the point of dichotomization (in which case the dichot-
omized exposure is a representation of the true risk factor).
However, provided that the instrumental variable assump-
tions are satisfied for the continuous risk factor, testing for
an association with the outcome is still a valid test of the
causal null hypothesis for the binary exposure.
There are two main consequences of this. First, such a
Mendelian randomization study should be conceptualized
as an investigation into the (possibly latent) underlying
continuous risk factor, rather than the binary
dichotomization of this variable. At minimum, the instru-
mental variable assumptions should be assessed with the
continuous risk factor in mind. Second, a causal estimate
from a Mendelian randomization investigation with a
dichotomized binary exposure does not have a clear
interpretation due to the binary exposure variable not
capturing the true causal relationship. There are several
reasons why a Mendelian randomization estimate may
differ from the effect of an intervention even for a con-
tinuous exposure (for example, genetic variants have long-
term influences acting from the beginning of life, whereas
interventions are more short-term and are applied to mature
individuals) [8, 22]. With a binary exposure, these concerns
are even greater.
Causal estimation with a binary exposure
Because of these issues, several authors have recom-
mended that Mendelian randomization investigations
should only test the causal null hypothesis, rather than
attempt to calculate a causal estimate [13, 23]. With a
single genetic variant, this can be achieved by testing for an
association between the variant and the outcome. With
multiple genetic variants, the most efficient test of the
causal null hypothesis is achieved by the IV estimate
(under the homogeneity assumptions, the two-stage least
squares estimate, or equivalently the inverse-variance
weighted estimate, is the optimally efficient combination of
the instruments for testing for a causal effect [26])—hence
we may want to perform IV estimation to test the causal
null even if the IV estimate is regarded as a test statistic
and does not have a clear interpretation as a causal effect.
Suppose that we want to calculate a causal effect with a
binary exposure, under the assumption that the exposure
has a stepwise effect on the outcome (that is, it truly is a
dichotomous exposure). This may be because we truly
believe in the homogeneity assumptions, or we truly
believe in the monotonicity assumption and regard the
genetic compliers as a worthwhile subgroup of the
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population in which to estimate an average causal effect.
Or, more likely, because a causal effect estimate is required
for pragmatic reasons, such as to perform a power calcu-
lation or to inform policymakers of the expected impact of
intervention on the exposure. Other reasons for estimating
a causal parameter include efficient testing of the causal
null hypothesis with multiple candidate instrumental vari-
ables, and using a robust method with multiple genetic
variants (such as the MR-Egger method [6] or weighted
median method [7]—these methods make weaker
assumptions, not requiring all genetic variants to satisfy the
instrumental variable assumptions). If the binary exposure
is a dichotomization of a continuous risk factor, then power
calculations are likely to be conservative, as the effect of
the genetic variant on the outcome will not be fully cap-
tured by the binary exposure.
Two options for causal estimation are: (1) estimating the
effect on the outcome per (say) 1% absolute increase in the
probability of the exposure; (2) estimating the effect on the
outcome per (say) doubling of the probability (or odds) of
the exposure. We concentrate on estimation methods based
on regression (usually linear or logistic) for several rea-
sons. First, often researchers perform their analyses using
summarized association estimates—beta-coefficients from
regression analyses of the exposure and outcome on a
genetic variant—and do not have access to individual-level
data. These beta-coefficients represent the average change
in the trait (exposure or outcome) per additional copy of the
effect allele. Secondly, these approaches result in causal
estimates with a simple and relevant interpretation, and
which can be compared to estimates in the literature from
other analytical approaches. Thirdly, often there are tech-
nical restrictions on the data analysis—for example, it may
be necessary to fit a mixed model to account for relatedness
between individuals, to adjust for several principal com-
ponents of ancestry, or to provide a coordinated approach
to analysis across different datasets. These restrictions are
easiest to accommodate in a regression framework. These
estimation procedures require strict linearity and homo-
geneity assumptions; full details are available elsewhere
[13, 15]. The parametric assumptions for these two options
are mutually incompatible. Additionally, regression coef-
ficients will generally be variation dependent on the base-
line risk, a nuisance parameter [20]. If individual-level data
are available, then alternative approaches to estimation can
be taken [4, 25].
If the genetic associations with the exposure are esti-
mated using linear regression, then they represent absolute
changes in the prevalence of the exposure. This enables
estimation of the causal effect of an intervention in the
prevalence of the exposure on an absolute scale. It is
sensible to scale the causal effect to consider a modest
increase in the prevalence of the exposure (say a 1% or a
10% increase), as a unit increase would represent the
average causal effect of a population intervention from 0%
prevalence of the exposure to 100% prevalence—an
unrealistic intervention in practice. However, absolute
associations with a binary variable do not make sense in
case-control settings (where cases are those with the
exposure), as they depend on the ratio of cases to controls
chosen by the investigator.
If the genetic associations with the exposure are esti-
mated using logistic regression, then they represent log
odds ratios. The causal estimate would then represent the
change in the outcome per unit change in the exposure on
the log odds scale. A unit increase in the log odds of a
variable corresponds to a 2.72 (¼ exp 1)-fold multiplicative
increase in the odds of the variable. If the exposure is rare
then the odds of the exposure is approximately equal to the
probability of the exposure. The causal estimate represents
the average change in the outcome per 2.72-fold increase in
the prevalence of the exposure (for example, an increase in
the exposure prevalence from 1 to 2.72%). It may be more
interpretable to think instead about the average change in
the outcome per doubling (2-fold increase) in the preva-
lence of the exposure. This can be obtained by multiplying
the causal estimate by 0.693 (¼ loge 2).
Discussion
In this short manuscript, we have discussed statistical
issues for Mendelian randomization with a binary expo-
sure. A summary of the arguments made in the paper is
provided as Fig. 1. Under the more plausible assumption of
monotonicity, the estimate from a Mendelian randomiza-
tion study with a binary exposure represents the average
causal effect in ‘compliers’; the subgroup of individuals for
whom the presence or absence of the genetic variant used
as an instrument determines whether individuals have the
exposure present or not. Under the less plausible assump-
tion of homogeneity, the estimate of the causal effect only
makes sense if the effect of the exposure on the outcome
has a strict stepwise form—only changes in whether the
binary exposure is present or absent will affect the out-
come. If the binary exposure is a dichotomization of a
continuous variable, then the causal estimate does not have
a clear interpretation. In such a case, causal inferences will
only be valid provided that the instrumental variable
assumptions are satisfied for the continuous risk factor—in
particular, if the effect of the genetic variant on the out-
come is completely mediated via the continuous risk factor.
However, as the effect of the genetic variant on the out-
come is not completely mediated via the binary exposure,
power calculations are likely to be conservative. Addi-
tionally, no particular significance should be assigned to
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the point of dichotomization of a continuous risk factor—if
a Mendelian randomization investigation suggests that
hypertension affects a disease outcome, clinical interven-
tions should not focus specifically on lowering blood
pressure above a certain cutpoint, or on individuals with
blood pressure values close to that cutpoint.
We have concentrated here on issues that are specific to
the use of a binary exposure variable. There are several
other considerations in a Mendelian randomization inves-
tigation, such as choice of genetic variants, validity of the
instrumental variable assumptions, measurement error in
the exposure, and similarity between samples in a two-
sample Mendelian randomization analysis (where the
genetic associations with the exposure and the genetic
associations with the outcome are estimated in different
datasets). While classical measurement error in the expo-
sure does not affect asymptotic estimates from instrumental
variable analysis for valid instruments [18], it will affect
estimates with a dichotomized exposure variable, as mea-
surement error in the continuous risk factor will lead to
misclassification of the binary exposure and hence attenu-
ation of the genetic association with the exposure (but not
in the genetic associations with the outcome). In a two-
sample setting, consistent estimation for a dichotomized
exposure requires the stepwise effect of the exposure to act
at the same level of the exposure in both populations.
Otherwise, all considerations for a Mendelian randomiza-
tion analysis with a continuous exposure are similarly
relevant for a Mendelian randomization analysis with a
binary exposure.
In summary, applying Mendelian randomization with a
binary exposure requires careful consideration. When the
binary exposure is a dichotomization of an underlying
continuous risk factor, causal assumptions should be
assessed and causal inferences should be conceptualized
with respect to the underlying continuous risk factor. Tests
for causal effects may be achieved readily without using
the exposure information, but estimation procedures for a
binary exposure require strong assumptions that are unli-
kely to be biologically plausible in common Mendelian
randomization settings.
Acknowledgements The authors would like to thank Sonja A
Swanson for her contribution to an earlier draft of this manuscript.
Fig. 1 Flow diagram illustrating the steps needed to consider when considering whether to estimate a parameter in a Mendelian randomization
investigation or not with a binary risk factor
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